Stockscreener 앱 받기
73.22
3.43%
-2.60
시간 외 거래:
74.00
0.78
+1.07%
전일 마감가:
$75.82
열려 있는:
$75.75
하루 거래량:
862.46K
Relative Volume:
0.67
시가총액:
$2.53B
수익:
$635.89M
순이익/손실:
$171.92M
주가수익비율:
16.81
EPS:
4.357
순현금흐름:
$151.36M
1주 성능:
-2.07%
1개월 성능:
+15.85%
6개월 성능:
-39.95%
1년 성능:
-46.24%
1일 변동 폭
$72.83
$77.50
1주일 범위
$71.33
$77.50
52주 변동 폭
$60.10
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
명칭
Transmedics Group Inc
전화
(978) 552-0900
주소
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
73.22 | 2.61B | 635.89M | 171.92M | 151.36M | 4.357 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-23 | 업그레이드 | Needham | Hold → Buy |
| 2025-10-13 | 개시 | Jefferies | Buy |
| 2025-09-16 | 개시 | Evercore ISI | Outperform |
| 2025-09-04 | 개시 | Stifel | Hold |
| 2024-12-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-11-22 | 다운그레이드 | Needham | Buy → Hold |
| 2024-10-29 | 재확인 | Needham | Buy |
| 2024-10-29 | 재확인 | Oppenheimer | Outperform |
| 2024-09-24 | 개시 | Robert W. Baird | Outperform |
| 2024-08-21 | 개시 | Needham | Buy |
| 2024-06-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-06-04 | 개시 | Stephens | Overweight |
| 2024-03-28 | 개시 | Piper Sandler | Overweight |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2022-08-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-10-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-04-07 | 개시 | Oppenheimer | Outperform |
| 2019-05-28 | 개시 | Canaccord Genuity | Buy |
| 2019-05-28 | 개시 | Cowen | Outperform |
| 2019-05-28 | 개시 | JP Morgan | Overweight |
| 2019-05-28 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
Transmedics Group Inc 주식(TMDX)의 최신 뉴스
[144] TransMedics Group, Inc. SEC Filing - Stock Titan
Q1 2026 Transmedics Group Inc Earnings Call Transcript - GuruFocus
TMDX News | TRANSMEDICS GROUP INC (NASDAQ:TMDX) - ChartMill
Law firm investigates TransMedics after margin pressure and investment disclosures hurt stock price - Pluang
Johnson Fistel Investigates TransMedics Group, Inc. (TMDX) After Recent Disclosures Concerning ... - Enidnews.com
Johnson Fistel Investigates TransMedics Group, Inc. (TMDX) - GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus
TransMedics Group Jumps 5.8% Amid Sector-Wide Rally - AlphaStreet
TransMedics: Why I'm Still Bullish After The Collapse (NASDAQ:TMDX) - Seeking Alpha
TransMedics Group, Inc. Trade Ideas — XETR:8T8 - TradingView
Price to book ratio of TransMedics Group, Inc. – XETR:8T8 - TradingView
Will Analyst Focus on TransMedics’ OCS Platform and Financial Metrics Change TransMedics Group’s (TMDX) Narrative? - Yahoo Finance
TransMedics faces earnings test as jet fuel costs weigh By Investing.com - Investing.com Australia
TransMedics Group Inc Stock Operating Data - GuruFocus
Oppenheimer downgrades TransMedics stock rating on sentiment concerns - Investing.com
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market - AOL.com
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market - The Motley Fool
TransMedics Group Inc (NASDAQ:TMDX): An Affordable Growth Play With Strong Fundamentals - ChartMill
Earnings call transcript: TransMedics Q1 2026 misses EPS forecast, stock stable - Investing.com Australia
TransMedics Group, Inc. (TMDX) Presents at 46th Annual William Blair Growth Stock ConferenceSlideshow - Seeking Alpha
TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Oppenheimer downgrades TransMedics stock rating on sentiment concerns By Investing.com - Investing.com UK
TMDX: Revolutionizing organ transplantation with record utilization rates and ambitious global growth targets - TradingView
TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Rating of "Hold" by Brokerages - MarketBeat
TransMedics Group, Inc. (TMDX) Stock Analysis: A 73.78% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
Reasons to retain TransMedics stock in your portfolio for now - MSN
What Drove TransMedics' Stellar Q4 2025 Performance - Kavout
Is TransMedics Group Inc (TMDX) a Bargain After 3.3% Drop? GF Va - GuruFocus
Reasons to Retain TransMedics Stock in Your Portfolio for Now - Yahoo Finance
Retail Traders Swarm TransMedics After Q3 Print— Retail Bulls Call It A ‘Hardcore Dip Buy’ - MSN
Avoiding Lag: Real-Time Signals in (TMDX) Movement - Stock Traders Daily
TMDX Maintained by Stifel -- Price Target Lowered to $75.00 - GuruFocus
TransMedics Group Inc (TMDX) Stock Price, Trades & News - GuruFocus
Stifel Nicolaus Lowers TransMedics Group (NASDAQ:TMDX) Price Target to $75.00 - MarketBeat
Stifel cuts TransMedics stock price target on heart market weakness - Investing.com
Stifel cuts TransMedics stock price target on heart market weakness By Investing.com - Investing.com India
TransMedics: Despite Earnings Miss, Growth Story Remains Intact (NASDAQ:TMDX) - Seeking Alpha
TransMedics Group, Inc. (TMDX) Stock Analysis: Unveiling a 71% Potential Upside in the Medical Device Sector - DirectorsTalk Interviews
TransMedics Group Inc Stock Warning Signs | MIL:1TMDX - GuruFocus
TMDX SEC FilingsTransmedics Group 10-K, 10-Q, 8-K Forms - Stock Titan
TransMedics Group Inc (TMDX) Stock Price, Quote, News & History - Benzinga
TransMedics (TMDX) director receives 2,922 RSU award, holds 5,788 shares - Stock Titan
Director at TransMedics (TMDX) receives 2,922 RSUs, lifting holdings to 15,056 shares - Stock Titan
TransMedics (TMDX) director Merilee Raines receives 2,922 RSU award - Stock Titan
TransMedics (TMDX) director receives 2,922 RSUs in equity grant - Stock Titan
Director at TransMedics (TMDX) receives 2,922 RSU equity grant, holds 5,788 shares - Stock Titan
[Form 4] TransMedics Group, Inc. Insider Trading Activity - Stock Titan
TransMedics (TMDX) director Edwin Kania awarded 2,922 RSUs, now holds over 300K shares - Stock Titan
TransMedics (TMDX) officer receives RSU and stock option grants tied to service - Stock Titan
TransMedics (NASDAQ: TMDX) investors approve directors, pay, stock plan and auditor - Stock Titan
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - marketscreener.com
Transmedics Group Inc (TMDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Transmedics Group Inc 주식 (TMDX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Lovell Stephanie | Director |
Mar 04 '26 |
Sale |
149.62 |
1,193 |
178,497 |
2,866 |
| Weill David | Director |
Mar 04 '26 |
Option Exercise |
14.20 |
3,571 |
50,708 |
15,705 |
| Weill David | Director |
Mar 04 '26 |
Sale |
146.82 |
3,571 |
524,294 |
12,134 |
| Hernandez Gerardo | Chief Financial Officer |
Mar 04 '26 |
Option Exercise |
71.17 |
7,236 |
515,001 |
20,601 |
| Hernandez Gerardo | Chief Financial Officer |
Mar 04 '26 |
Sale |
147.21 |
7,236 |
1,065,212 |
14,689 |
| Hernandez Gerardo | Chief Financial Officer |
Mar 02 '26 |
Sale |
139.12 |
375 |
52,170 |
14,689 |
| Ranganath Anil P. | See remarks |
Mar 02 '26 |
Sale |
139.12 |
864 |
120,200 |
13,091 |
| Corcoran Nicholas | See remarks |
Mar 02 '26 |
Sale |
139.12 |
2,966 |
412,630 |
29,831 |
2.43%
자본화:
|
볼륨(24시간):